236 top medical experts on Pantothenate Kinase-Associated Neurodegeneration across 34 countries and 17 U.S. states, including 59 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pantothenate Kinase-Associated Neurodegeneration: A rare autosomal recessive degenerative disorder which usually presents in late childhood or adolescence. Clinical manifestations include progressive muscle spasticity; hyperreflexia; muscle rigidity; dystonia; dysarthria; and intellectual deterioration which progresses to severe dementia over several years. (From Adams et al., Principles of Neurology, 6th ed, p972; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp972-929)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Basal Ganglia Diseases (3,177), Movement Disorders (2,573), Nervous System Heredodegenerative Disorders (865), Neuroaxonal Dystrophies (1,017).
  4. Clinical Trials ClinicalTrials.gov : at least 9 including 1 Active, 3 Completed, 1 Recruiting
  5. Synonyms: Pigmentary Pallidal Degeneration


  

        

                    


    Computing Expert Listing ...

);